Perigon Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.08M Sell
20,954
-371
-2% -$48.4K 0.04% 370
2025
Q4
$2.59M Buy
21,325
+716
+3% +$89.8K 0.05% 314
2025
Q3
$2.31M Buy
20,609
+1,403
+7% +$164K 0.05% 320
2025
Q2
$2.57M Buy
19,206
+386
+2% +$42.4K 0.06% 285
2025
Q1
$1.27M Buy
18,820
+4,543
+32% +$312K 0.03% 399
2024
Q4
$828K Buy
14,277
+9,707
+212% +$904K 0.02% 497
2024
Q3
$717K Buy
4,570
+1,229
+37% +$189K 0.02% 515
2024
Q2
$503K Buy
+3,341
New +$401K 0.01% 531

Other funds holding TMDX

Perigon Wealth Management's TMDX Position: Q1 2026 in Review

Perigon Wealth Management reduced its Transmedics (TMDX) stake by 1.7% in Q1 2026, selling an estimated $48.4K and leaving 20,954 shares worth $2.08M. The position accounts for 0.04% of the portfolio, ranked #370.

Perigon Wealth Management first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.59M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Perigon Wealth Management held 20,954 shares of Transmedics worth $2.08M as of Q1 2026.
  • Perigon Wealth Management sold 371 Transmedics shares in Q1 2026, an estimated $48.4K.
  • Transmedics made up 0.04% of Perigon Wealth Management's portfolio in Q1 2026, its #370 holding.
  • Perigon Wealth Management first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
  • Perigon Wealth Management's Transmedics position peaked at $2.59M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.